PubMed · 1994 · 95 citations · 18 references
Life SciencesImmunologyPathologyAutoimmunityImmunopathologyInflammationAutoantibodiesAutoimmune DiseasesAutoimmune Rheumatic DiseasesImmune-mediated DiseaseRenal ImmunopathologySystemic Lupus ErythematosusAdjuvant UseGlomerular AutoimmunityImmune Complex-mediated Glomerular InjuryLymphocytic InflammationOrgan-specific Autoimmune Disease MechanismsOrgan-specific AutoimmunityPerivascular Lymphocytic InfiltrateRenal Immune Complex Deposition
Non-obese diabetic (NOD) mice spontaneously develop organ-specific autoimmunity and are widely used as a model for diabetes. Aged NOD mice also exhibit some features of non-organ-specific autoimmune rheumatic disease such as anti-nuclear antibodies and late-onset haemolytic anaemia. Here, we report that a single dose of 2.6 x 10(7) heat-killed bacillus Calmette-Guérin (BCG) i.v. in 8-week-old NOD mice prevented diabetes but precipitated a syndrome similar to systemic lupus erythematosus (SLE). Treated mice developed haemolytic anaemia, anti-DNA and anti-Sm anti-nuclear autoantibodies and an increased severity of sialadenitis. Perivascular lymphocytic infiltration in the kidneys and glomerular immune complex deposition were also found. The action of BCG appeared to be mediated by an adjuvant-like activity as treated mice showed a substantial increase in reticuloendothelial cell function and enhanced antigen presentation capacity.
18
Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg
Silvia M. Vidal, Danielle Malo, Kyle Vogan et al. · Cell · 1993 · 1.1K citations
The NOD Mouse: Recessive Diabetogenic Gene in the Major Histocompatibility Complex
Masakazu Hattori, John B. Buse, R. A. JACKSON et al. · Science · 1986 · 415 citations
Life Sciences, Genetics, Immunology +15
Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy
Michel Sadelain, Hui-Yu Qin, Jana Lauzon et al. · Diabetes · 1990 · 265 citations